ITRM(Delisted)
Iterum Therapeutics·NASDAQ
--
--(--)
Iterum Therapeutics (ITRM) Financial Statements
Iterum Therapeutics (ITRM) Cash Flow Statement
During Q3 2025, Iterum Therapeutics (ITRM) generated -7.45M in cash flow from operating activities, -12.00K from investing activities, and 5.43M from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2017 | Q1,2018 | Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2017 | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -5.43M -- | -11.64M -114.17% | -15.05M -29.32% | -27.39M -81.96% | -1.13M +95.87% | -3.40M -200.80% | -9.59M -181.64% | -12.84M -- | -13.08M -36.42% | -6.76M -- | -2.67M -- | -4.26M +66.86% | -3.06M +76.61% | -4.75M +29.71% | -7.45M -178.71% | -19.51M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -12.36M -- | -7.10M -- | -5.00M -- | -6.09M -- | -6.58M +46.76% | -4.89M +31.12% | -6.51M -30.26% | -8.98M -47.34% | -26.96M -- |
Depreciation and Amortization | -- -- | 31.00K -- | 133.00K +329.03% | 1.65M +1142.86% | 2.41M +45.61% | 601.00K -75.03% | 1.01M +68.72% | 440.00K -- | 7.00K -99.31% | 8.00K -- | 8.00K -- | 261.00K -40.68% | 349.00K +4885.71% | 351.00K +4287.50% | 355.00K +4337.50% | 1.32M -- |
Stock-based Compensation | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 139.00K -- | 138.00K -- | 68.00K -- | 68.00K -- | 89.00K -35.97% | 61.00K -55.80% | 56.00K -17.65% | 53.00K -22.06% | 259.00K -- |
Interest Income(expense) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 782.00K -- | 749.00K -- | 751.00K -- | 2.73M -- | -921.00K -217.77% | 686.00K -8.41% | 449.00K -40.21% | 562.00K -79.44% | 776.00K -- |
Change in Working Capital | 313.00K -- | 349.00K +11.50% | 4.74M +1259.03% | -15.02M -416.72% | 4.25M +128.29% | 1.05M -75.32% | -2.72M -359.29% | -2.29M -- | -7.76M -185.22% | -3.48M -- | -73.00K -- | -1.42M +38.13% | -266.00K +96.57% | -171.00K +95.09% | -991.00K -1257.53% | -2.85M -- |
Change in Accounts Receivable | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -448.00K -- | -- -- |
Change in Inventories | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | -533.00K -- | -415.00K -- | -201.00K -- | -1.15M -- |
Change in Accounts Payable | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -518.00K -- | -2.03M -- | -2.14M -- | 14.00K -- | -584.00K -12.74% | 161.00K +107.93% | 777.00K +136.24% | -612.00K -4471.43% | -258.00K -- |
Change in Other Working Capital | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.78M -- | -5.73M -- | -1.34M -- | -87.00K -- | -836.00K +52.95% | 106.00K +101.85% | -533.00K +60.10% | 270.00K +410.34% | -993.00K -- |
Other Non-cash Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 453.00K -- | 882.00K -- | 891.00K -- | 686.00K -- | 4.32M +852.98% | 1.00M +13.49% | 1.07M +20.43% | 1.55M +126.38% | 7.94M -- |
Net Cash Flows from Investing Activities | -518.00K -- | 9.36M +1906.37% | 35.09M +275.01% | -- -- | -33.92M -- | 9.59M +128.28% | 5.11M -46.77% | 13.52M -- | 7.21M +41.23% | 4.20M -- | 5.70M -- | 1.10M -91.87% | -2.00K -100.03% | 0 -100.00% | -12.00K -100.21% | 1.09M -- |
Change in PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -2.00K -- | 0 -- | 0 -- | -2.00K -- | 0 +100.00% | -12.00K -- | -14.00K -- |
Purchase of PPE and Intangible Assets | 518.00K -- | 21.00K -95.95% | 10.00K -52.38% | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 2.00K -- | 0 -- | 0 -- | 2.00K -- | 0 -100.00% | 12.00K -- | 14.00K -- |
Change in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 13.52M -- | 7.21M -- | 4.20M -- | 5.70M -- | 1.10M -91.87% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 1.10M -- |
Decrease in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 18.70M -- | 13.70M -- | 10.10M -- | 5.70M -- | 1.10M -94.12% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 1.10M -- |
Increase in Investments | -- -- | 6.37M -- | -- -- | -- -- | 33.92M -- | 11.31M -66.67% | 3.89M -65.58% | 5.18M -- | 6.49M +66.73% | 5.90M -- | 0 -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -- | -- -- |
Net Cash Flows from Financing Activities | -- -- | 32.18M -- | 49.00K -99.85% | 45.87M +93514.29% | 86.98M +89.62% | -2.25M -102.59% | 235.00K +110.44% | 589.00K -- | 7.22M +2971.06% | 167.00K -- | 5.43M -- | 13.88M +2256.03% | -8.39M -216.23% | 5.12M +2965.87% | 5.43M +0.04% | 16.04M -- |
Change in Debt | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -14.74M -- | 0 -- | 0 -- | -14.74M -- |
Repayment of long-term Debt | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- |
Change in Capital Stock | -- -- | -- -- | -- -- | -- -- | 88.61M -- | 6.00K -99.99% | 235.00K +3816.67% | 589.00K -- | 7.22M +2971.06% | 167.00K -- | 5.43M -- | 13.88M +2256.03% | 6.36M -11.92% | 5.12M +2965.87% | 5.43M +0.04% | 30.79M -- |
Increase in Capital Stock | -- -- | -- -- | -- -- | -- -- | 88.61M -- | 6.00K -99.99% | 235.00K +3816.67% | 589.00K -- | 7.22M +2971.06% | 167.00K -- | 5.43M -- | 13.88M +2256.03% | 6.36M -11.92% | 5.12M +2965.87% | 5.43M +0.04% | 30.79M -- |
Effect of Foreign Exchange Rate Changes | -- -- | -- -- | -34.00K -- | -24.00K +29.41% | -6.00K +75.00% | -22.00K -266.67% | -12.00K +45.45% | -14.00K -- | -27.00K -125.00% | -18.00K -- | -28.00K -- | -2.00K +85.71% | -23.00K +14.81% | 5.00K +127.78% | -2.00K +92.86% | -22.00K -- |
Net Increase in Cash and Cash Equivalents | -5.95M -- | 29.89M +602.15% | 20.05M -32.92% | 18.46M -7.96% | 51.92M +181.34% | 3.92M -92.46% | -4.26M -208.84% | 1.25M -- | 1.32M +130.93% | -2.41M -- | 8.43M -- | 10.72M +754.10% | -11.47M -970.49% | 374.00K +115.50% | -2.03M -124.07% | -2.41M -- |
Cash and Cash Equivalents at Beginning of Period | 24.81M -- | 8.48M -65.80% | 44.67M +426.47% | 4.89M -89.05% | 14.82M +202.92% | 27.51M +85.68% | 21.13M -23.21% | 4.85M -- | 6.11M -71.10% | 7.42M -- | 5.01M -- | 13.44M +177.11% | 24.16M +295.72% | 12.69M +70.90% | 13.06M +160.68% | 63.34M -- |
Cash and Cash Equivalents at End of Period | 18.86M -- | 38.38M +103.53% | 64.72M +68.65% | 23.35M -63.93% | 66.74M +185.86% | 31.43M -52.91% | 16.86M -46.33% | 6.11M -- | 7.42M -55.99% | 5.01M -- | 13.44M -- | 24.16M +295.72% | 12.69M +70.90% | 13.06M +160.68% | 11.03M -17.92% | 60.94M -- |
You can ask Aime
No Data
